Tivic Health Shares Insights on Progress and Future Aspirations

CEO Letter to Shareholders from Tivic Health

Tivic Health Systems, Inc. (Nasdaq: TIVC) is excited to share its annual CEO letter, reflecting on the achievements of the past year and outlining goals for the upcoming period.

Dear Fellow Shareholders,

As we wrap up another year, it’s important to highlight the significant strides we’ve made in our quest to enhance health technologies and deliver meaningful solutions to our customers.

Key Developments in Our Business Operations

Throughout the past year, we have focused on refining our commercial business. A pivotal achievement includes the launch of ClearUP 2.0, which not only enhances customer satisfaction but also resolves previous technical challenges encountered.

Additionally, we established valuable partnerships with prominent retail companies, giving us an edge in reaching our customers more effectively. Our customer feedback has reflected our commitment to excellence, with an impressive average rating of 4.4 Stars, leading to fewer return issues.

Our strategic approach to marketing has also undergone enhancements, allowing us to optimize our outreach efforts. These developments have resulted in a reshaped supply chain that now boasts a gross margin exceeding 65%, a notable improvement from 2023.

Future Direction: Vagus Nerve Stimulation (VNS)

In contemplating our future, we’re particularly excited about our focus on Vagus Nerve Stimulation (VNS). This innovative technology, traditionally reliant on surgical implants, is gaining momentum in the medical field.

Research indicates the VNS market is projected to reach a value of $21 billion over the next five years, growing at a robust rate. Our objective is to harness this transformative potential through non-invasive methods. Our approach not only minimizes costs but also delivers comparable clinical outcomes to traditional surgical methods.

Clinical Collaborations and Progress

This past year, we successfully completed a pilot study in collaboration with leading medical institutions, demonstrating our non-invasive technique's ability to drive significant improvements across various health metrics. We are now advancing to additional studies that will further refine our methods and parameters.

Emphasizing Intellectual Property and Market Opportunities

We’re proud to report that our investment in research and innovation is yielding fruit, with a growing portfolio of patents crucial for protecting our advancements globally. Currently, we hold 16 issued and 10 pending patents across different regions, laying the foundation for expanding our market reach.

Companies are increasingly acknowledging the advantages of VNS, and we aim to seize over $30 billion worth of opportunities that exist in the current healthcare landscape.

Looking Ahead: Strategic Goals for 2025

As we move into the new year, our ambitions intensify. With plans to boost cash flow from our ClearUP product, we’re optimistic about our collaboration with esteemed researchers in the health tech sector. Furthermore, we intend to embark on disease-specific clinical trials that bring us closer to regulatory approvals for our groundbreaking treatments.

We anticipate that our ncVNS initiatives will be crucial in enhancing shareholder value over time. We are also actively evaluating strategies to ensure compliance with Nasdaq listing requirements.

The hard work and dedication of our team continues to inspire our efforts towards achieving our mission. Together with our stakeholders, we are devoted to revolutionizing the future of healthcare.

With excitement for what lies ahead, we look forward to travelling this path in the year ahead.

Sincerely,

Jennifer Ernst
Chief Executive Officer

About Tivic Health

Tivic Health is dedicated to pioneering bioelectronic medicine, utilizing advanced technology to stimulate critical nerve structures. Our approach provides non-invasive treatment options, enabling safe and effective therapeutic solutions.

Frequently Asked Questions

What are Tivic Health's main products?

Tivic Health's flagship product is ClearUP, an innovative handheld bioelectronic device designed for sinus relief.

What is Vagus Nerve Stimulation (VNS)?

VNS is a technology that stimulates the vagus nerve to treat various medical conditions, traditionally through surgical implants, now being explored non-invasively by Tivic Health.

How does Tivic Health ensure product safety?

Tivic Health prioritizes safety through rigorous clinical trials and adherence to regulatory guidelines.

What are the company's goals for 2025?

Tivic Health aims to expand its commercial offerings, enhance its clinical trials, and achieve regulatory approvals for its VNS products.

Where can I learn more about Tivic Health?

For more information about Tivic Health and its initiatives, visit their official website.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.